Muralidhar L Hegde Selected Research

Muralidhar L Hegde Research Topics

Disease

14	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 10/2003
11	Parkinson Disease (Parkinson's Disease) 01/2020 - 10/2003
9	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2004
7	Neoplasms (Cancer) 11/2021 - 07/2011
6	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2024 - 11/2018
6	Sarcoma (Soft Tissue Sarcoma) 03/2024 - 10/2016
4	Mitochondrial Diseases (Mitochondrial Disease) 03/2024 - 01/2020
4	Disease Progression 01/2021 - 10/2016
3	Motor Neuron Disease (Primary Lateral Sclerosis) 03/2024 - 10/2016
3	Inflammation (Inflammations) 01/2024 - 08/2013
3	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2024 - 01/2015
3	Nervous System Diseases (Neurological Disorders) 04/2022 - 04/2012
3	Genomic Instability 01/2020 - 07/2011
2	Stroke (Strokes) 11/2021 - 01/2014
2	Hemorrhage 11/2021 - 01/2020
2	Carcinogenesis 07/2017 - 10/2013
1	Cerebral Hemorrhage 01/2020
1	Amyloid Plaque 10/2019
1	Infections 02/2019
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2018
1	Polyps 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Chromosomal Instability (Chromosome Stability) 07/2017
1	Liposarcoma 10/2016
1	Fibrosis (Cirrhosis) 12/2015
1	Chronic Disease (Chronic Diseases) 08/2014
1	Hypersensitivity (Allergy) 04/2014
1	Wounds and Injuries (Trauma) 01/2014
1	Lung Neoplasms (Lung Cancer) 06/2012
1	Nervous System Heredodegenerative Disorders 04/2012
1	Aneuploidy (Aneuploid) 07/2011
1	Tetraploidy 07/2011
1	Neuroblastoma 09/2010

Drug/Important Bio-Agent (IBA)

22	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2004
10	Proteins (Proteins, Gene)FDA Link 04/2022 - 09/2006
6	IronIBA 01/2021 - 09/2010
6	SynucleinsIBA 01/2020 - 10/2003
5	MetalsIBA 01/2021 - 01/2009
5	alpha-SynucleinIBA 01/2020 - 10/2003
4	CopperIBA 01/2021 - 09/2010
4	Amyloid (Amyloid Fibrils)IBA 01/2021 - 10/2019
4	Amyloidogenic ProteinsIBA 01/2020 - 01/2010
4	RNA (Ribonucleic Acid)IBA 01/2020 - 10/2016
4	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2020 - 10/2016
4	Amyloid beta-PeptidesIBA 10/2019 - 01/2004
3	Peptides (Polypeptides)IBA 01/2021 - 01/2004
3	8-hydroxyguanineIBA 09/2014 - 08/2013
3	DNA Glycosylases (DNA Glycosylase)IBA 07/2014 - 09/2007
2	Mitochondrial DNA (mtDNA)IBA 03/2024 - 07/2023
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2024 - 01/2019
2	Polynucleotide 5'-Hydroxyl-Kinase (Kinase, Polynucleotide)IBA 01/2024 - 01/2015
2	EnzymesIBA 01/2024 - 01/2015
2	ChromatinIBA 11/2021 - 01/2017
2	PolyphenolsIBA 01/2021 - 11/2019
2	Ataxin-3IBA 01/2020 - 01/2015
2	Ligases (Synthetase)IBA 09/2019 - 01/2019
2	Monomeric GTP-Binding ProteinsIBA 01/2019 - 09/2014
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 04/2022
1	Oxygen (Dioxygen)IBA 11/2021
1	ZincIBA 01/2021
1	CurcuminIBA 01/2021
1	Hemin (Panhematin)FDA Link 01/2020
1	CarbonIBA 01/2020
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	Carotenoids (Carotene)IBA 11/2019
1	indoleIBA 10/2019
1	CannabinoidsIBA 02/2019
1	sinomenineIBA 11/2018
1	Radiation-Sensitizing AgentsIBA 11/2018
1	IsothiocyanatesIBA 01/2018
1	Histones (Histone)IBA 01/2018
1	sulforaphaneIBA 01/2018
1	1H-tetrazole (tetrazole)IBA 01/2018
1	histone deacetylase 3IBA 01/2018
1	Lysine AcetyltransferasesIBA 01/2018
1	CollagenIBA 12/2015
1	polyglutamineIBA 01/2015
1	CytokinesIBA 09/2014
1	ChemokinesIBA 09/2014
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 08/2014
1	AllergensIBA 04/2014
1	Immunoglobulin E (IgE)IBA 04/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014
1	B-Form DNA (B-DNA)IBA 04/2012
1	Z-Form DNA (Z-DNA)IBA 04/2012
1	Exonucleases (3' 5' Exonuclease)IBA 07/2011
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2011
1	Flap EndonucleasesIBA 07/2011
1	Chelating AgentsIBA 01/2011
1	Cell ExtractsIBA 09/2010
1	CytosineIBA 09/2010
1	DNA-(Apurinic or Apyrimidinic Site) Lyase (AP Endonuclease)IBA 09/2010
1	5-hydroxyuracilIBA 09/2010

Therapy/Procedure

8	Therapeutics 01/2020 - 01/2017
1	Secondary Prevention 11/2021
1	Critical Care (Surgical Intensive Care) 11/2021
1	Ligation 11/2018
1	Oral Administration 01/2018
1	Radiotherapy 11/2012